RSI Rush posts 165 percent Q1 2026 EPS beat shares tick modestly higher in todays trading session Why Oric Pharmaceuticals ORIC might be early to something big Grinds Lower 20260506 Goldman Sachs Group Inc GS Alternatives Division Leads 60M Series C Funding for Workplace Fintech Kashable Expanding Inclusive Growth Investment Portfolio Is CanFite Bio CANF stock a value play Momentum Building 20260501